2019 J.P. Morgan Health Care Investor Conference

Announcing The Launch Of Our New Website
January 3, 2019
DSI Sponsors DCAT in NYC
March 8, 2019

Each year, healthcare, pharmaceutical, and biotechnology executives attend the JP Morgan Healthcare Conference, some to tout recent developments, others just to bounce from session to session.

2019 J.P. Morgan Health Care Investor Conference and Biotech Showcase. Meet with DSI!

Each year, healthcare, pharmaceutical, and biotechnology executives attend the JP Morgan Healthcare Conference, some to tout recent developments, others just to bounce from session to session. I’ve been coming here for six years now to work with our clients who need actionable drug development guidance, so that their company may reach value inflection points. The meetings and events around town this week can bring tremendous opportunities, so keep us in mind to make the most of your time and plan to attend the must-see events to maximize your productivity. We work hard at DSI to make life science companies better at what you do in the Chemistry, Manufacturing and Controls (CMC) areas. We’ve learned that early stage companies need seasoned expertise to lead their product development forward, and mature companies need practical expertise to retain the agility that drives innovation.

Startups need a solid integrated development strategy, coupled with a credible plan (and budget!) to raise capital, whether it’s the first or fourth round. We strive to bring a collaborative and creative approach to your regulatory, CMC and quality efforts, so together we can bring life-changing products to patients as soon as possible. The products in development today are increasingly complex and demand a partner as ambitious and committed to success as you are. Our regulatory expertise in CMC can be a key element to your development programs.

The life science ecosystem has matured over the years and now is much more than a few multinational pharma companies; likewise, our work has matured and can be deployed as companies “grow up.” We leverage our expertise in process efficiency, technology adoption, process harmonization, inspection readiness, compliance programs and regulatory submissions to streamline your business and consequently move your programs forward. Having the support of our deeper department, who have “been there and done that,” can transform your company from good to great.

My team and I will be available throughout the week to brainstorm your next milestone and help you get there. To learn more about DSI, visit DSinPharmatics.com or contact Meranda Parascandola at mparascandola@dsinpharmatics.com so we connect in person!

DSI plans a series of networking events and private meetings concurrent to the 2019 J.P. Morgan Health Care Investor Conference. Contact us if you are interested in learning more or connecting with our leadership and subject matter experts. If you want to understand the shifting sands of CMC regulations, you’ll find no better partner during the infamous JP Morgan Healthcare Conference that took place this week in San Francisco.

Send us a message if you’d like to meet.